To further verify our hypothesis that the changes in MAMs resulted in renal lipid deposition in DN, we selected three MAM-control proteins, DsbA-L, PACS-2, and MFN-2, which have been proven by us and other groups to control the formation of MAMs (16, 28–30). The gene discussed is MFN2; the disease is liver dysplastic nodule.